MedElevator
Войти в исследования Asian Pacific journal of allergy and immunology · 2026
Type 2 high asthma phenotype in children: A multidimensional clustering analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bae Soyoung, Lee Hyejin
Аннотация
BACKGROUND: Asthma is a heterogeneous disease with diverse and poorly defined phenotypes, especially in children.
OBJECTIVE: We aimed to classify childhood asthma phenotypes using unsupervised cluster analysis based on type 2 (T2) biomarkers and to evaluate their clinical characteristics and outcomes.
METHODS: We retrospectively analyzed 614 pediatric patients. Hierarchical clustering was performed using four variables: age, absolute eosinophil count (AEC), eosinophil cationic protein (ECP), and total immunoglobulin E (IgE). Clinical characteristics and two-year clinical outcomes were compared across clusters. The effect of age was examined using Analysis of Covariance (ANCOVA) and age-tertile subgroup analyses.
RESULTS: Three distinct clusters were identified. Cluster 2, the T2-high asthma group (n = 157; median age: 8.0 years), was characterized by male predominance (69.4%), the highest levels of T2 biomarkers (AEC, ECP, IgE, FeNO; all P < 0.001), airway hyperresponsiveness (BDR, P = 0.024; PC20, P < 0.001), and reduced lung function (FEV1, P = 0.002). In contrast, Cluster 1 (n = 252; median age: 4.0 years) showed the highest exacerbation and steroid use rates but relatively low T2 biomarker levels. Cluster 3 (n = 205; median age: 12.0 years) had moderate T2 levels and the lowest exacerbation burden. After adjusting for age, Cluster 2 maintained 4-6 folds higher T2 biomarker levels compared to other clusters (all P <0.001). These cluster-specific differences were not observed in the age tertile subgroup analysis.
CONCLUSIONS: The identified school-age T2-high cluster in childhood asthma exhibits distinct immunological and clinical phenotypes, characterized by high airway hyperresponsiveness, atopic features, and decreased lung function.
OBJECTIVE: We aimed to classify childhood asthma phenotypes using unsupervised cluster analysis based on type 2 (T2) biomarkers and to evaluate their clinical characteristics and outcomes.
METHODS: We retrospectively analyzed 614 pediatric patients. Hierarchical clustering was performed using four variables: age, absolute eosinophil count (AEC), eosinophil cationic protein (ECP), and total immunoglobulin E (IgE). Clinical characteristics and two-year clinical outcomes were compared across clusters. The effect of age was examined using Analysis of Covariance (ANCOVA) and age-tertile subgroup analyses.
RESULTS: Three distinct clusters were identified. Cluster 2, the T2-high asthma group (n = 157; median age: 8.0 years), was characterized by male predominance (69.4%), the highest levels of T2 biomarkers (AEC, ECP, IgE, FeNO; all P < 0.001), airway hyperresponsiveness (BDR, P = 0.024; PC20, P < 0.001), and reduced lung function (FEV1, P = 0.002). In contrast, Cluster 1 (n = 252; median age: 4.0 years) showed the highest exacerbation and steroid use rates but relatively low T2 biomarker levels. Cluster 3 (n = 205; median age: 12.0 years) had moderate T2 levels and the lowest exacerbation burden. After adjusting for age, Cluster 2 maintained 4-6 folds higher T2 biomarker levels compared to other clusters (all P <0.001). These cluster-specific differences were not observed in the age tertile subgroup analysis.
CONCLUSIONS: The identified school-age T2-high cluster in childhood asthma exhibits distinct immunological and clinical phenotypes, characterized by high airway hyperresponsiveness, atopic features, and decreased lung function.